Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

101
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
101
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

203
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
203
Elements Crucial for Effective Psychotherapy01:25

Elements Crucial for Effective Psychotherapy

239
Research has highlighted several critical factors that influence the effectiveness of psychotherapy, such as the therapeutic alliance, the therapist, and the client.
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
239
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

90
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
90
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

283
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Model Misspecification on the Individual Causal Association in Surrogate Endpoint Evaluation.

Pharmaceutical statistics·2026
Same author

Evaluation of surrogate endpoints for survival outcomes using the surrogate package in R.

Computer methods and programs in biomedicine·2026
Same author

Integrating oral health screening into general practice: validation study of the Oral Health Screener.

Scientific reports·2026
Same author

Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases.

Statistics in medicine·2026
Same author

Handling Missing Data in Participants with Baseline but No Post-Baseline Data.

Pharmaceutical statistics·2026
Same author

A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2026

Related Experiment Video

Updated: Dec 3, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Identifying individual predictive factors for treatment efficacy.

Ariel Alonso1, Wim Van der Elst2, Lizet Sanchez3

  • 1I-BioStat, Catholic University of Leuven, Leuven, Belgium.

Biometrics
|October 31, 2020
PubMed
Summary

Identifying pretreatment predictors for cancer immunotherapy is crucial due to varied responses and high costs. This study introduces a novel method using causal inference to quantify how patient factors predict individual treatment effects, aiding personalized medicine.

Keywords:
causal inferencemultivariate predictorspersonalized medicineprediction of therapeutic success

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.4K

Related Experiment Videos

Last Updated: Dec 3, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.4K

Area of Science:

  • Biostatistics
  • Computational Biology
  • Oncology

Background:

  • Cancer immunotherapy response varies significantly among patients.
  • High treatment costs necessitate identifying patients most likely to benefit.
  • Predicting individual treatment effects is key for personalized cancer therapy.

Purpose of the Study:

  • To develop a robust methodology for evaluating pretreatment predictors of cancer immunotherapy efficacy.
  • To quantify the information conveyed by patient-specific variables on individual causal treatment effects.
  • To identify reliable predictors for therapeutic success in advanced lung cancer.

Main Methods:

  • Utilized causal inference to model the joint distribution of pretreatment predictors and individual causal treatment effects.
  • Introduced Predictive Causal Information (PCI), a metric to quantify predictive power.
  • Studied the properties of the PCI metric and applied it to a real-world case study.

Main Results:

  • Developed a novel causal inference framework for assessing predictive factors in immunotherapy.
  • Quantified the predictive information of pretreatment variables on individual treatment outcomes using PCI.
  • Successfully applied the methodology to identify predictors for a therapeutic vaccine in advanced lung cancer.

Conclusions:

  • The proposed causal inference strategy effectively evaluates individual predictive factors for cancer immunotherapy.
  • Predictive Causal Information (PCI) offers a valuable metric for quantifying predictive power.
  • The developed R library, EffectTreat, facilitates the application of this methodology in clinical research.